Adenosine type 1 (A1) receptors mediate protection against myocardial infarction produced by chronic, intermittent ingestion of ethanol in dogs. 2003

Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

BACKGROUND Chronic consumption of small amounts of ethanol protects myocardium from ischemic injury. We tested the hypothesis that adenosine type 1 (A(1)) receptors mediate these beneficial effects. METHODS Dogs (n=37) were fed with ethanol (1.5 g/kg) or water mixed with dry food twice per day for 12 weeks, fasted overnight before experimentation, and instrumented for measurement of hemodynamics. Dogs received intravenous drug vehicle (50% polyethylene glycol in 0.1 N sodium hydroxide and 0.9% saline over 15 min) or the selective A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 0.8 mg/kg over 15 min) and were subjected to a 60 min coronary artery occlusion followed by 3 h of reperfusion. Myocardial infarct size and transmural coronary collateral blood flow were measured with triphenyltetrazolium chloride staining and radioactive microspheres, respectively. RESULTS The area at risk (AAR) for infarction was similar between groups. Pretreatment with ethanol significantly reduced infarct size to 13+/-2% (n=7) of the AAR as compared to control experiments (26+/-2%; n=7). DPCPX abolished the protective effects of ethanol pretreatment (30+/-3%; n=7) but had no effect in dogs that did not receive ethanol (25+/-2%; n=7). No differences in transmural coronary collateral blood flow were observed between groups. CONCLUSIONS The present findings indicate that chronic ingestion of small amounts of ethanol produces myocardial protection that persists after the discontinuation of ethanol. The results indicate that A(1) receptors mediate ethanol-induced preconditioning in dogs independent of alterations in systemic hemodynamics or coronary collateral blood flow.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003097 Collateral Circulation Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels. Blood Circulation, Collateral,Circulation, Collateral,Collateral Blood Circulation,Collateral Circulation, Blood,Blood Collateral Circulation,Circulation, Blood Collateral,Circulation, Collateral Blood,Collateral Blood Circulations,Collateral Circulations,Collateral Circulations, Blood
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol

Related Publications

Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
July 1991, Circulation,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
January 2000, Neuroscience letters,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
April 2004, Pathophysiology : the official journal of the International Society for Pathophysiology,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
November 1994, The Biochemical journal,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
June 2010, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
September 2003, Proceedings of the National Academy of Sciences of the United States of America,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
February 2004, Journal of molecular endocrinology,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
January 1995, Biology of the neonate,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
March 2002, American journal of physiology. Heart and circulatory physiology,
Franz Kehl, and John G Krolikowski, and John F LaDisa, and Judy R Kersten, and David C Warltier, and Paul S Pagel
August 2022, Tissue & cell,
Copied contents to your clipboard!